A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies.
Dementia
Diabetes
Heart attack
Primary prevention
Risk factors
Risk prediction
Risk tool
Stroke
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
31 Oct 2024
31 Oct 2024
Historique:
received:
12
07
2024
accepted:
17
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
We aimed to develop risk tools for dementia, stroke, myocardial infarction (MI), and diabetes, for adults aged ≥ 65 years using shared risk factors. Data were obtained from 10 population-based cohorts (N = 41,755) with median follow-up time (years) for dementia, stroke, MI, and diabetes of 6.2, 7.0, 6.8, and 7.4, respectively. Disease-free participants at baseline were included, and 22 risk factors (sociodemographic, medical, lifestyle, laboratory biomarkers) were evaluated. Two risk tools (DemNCD and DemNCD-LR based on Fine and Gray sub-distribution and logistic regression [LR], respectively) were developed and validated. Predictive accuracies of these risk tools were assessed using Harrel's C-statistics and area under the curve (AUC) and 95% confidence interval (CI). Model calibration was conducted using Hosmer-Lemeshow goodness of fit test along calibration plots. Both the DemNCD and DemNCD-LR resulted in similar predictive accuracy for each outcome. The overall AUC (95% CI) for dementia, stroke, MI, and diabetes risk tool were 0·68 (0·65, 0·70), 0·58 (0·54, 0·61), 0·65 (0·61, 0·68), and 0·68 (0·64, 0·72), respectively, for males. For females, these figures were 0·65 (0·63, 0·67), 0·55 (0·52, 0·57), 0·65 (0·62, 0·68), and 0·61 (0·57, 0·65). The DemNCD is the first tool to predict both dementia and multiple cardio-metabolic diseases using comprehensive risk factors and provided similar predictive accuracy to existing risk tools. It has similar predictive accuracy as tools designed for single outcomes in this age-group. DemNCD has the potential to be used in community and clinical settings as it includes self-reported and routinely available clinical measures.
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to develop risk tools for dementia, stroke, myocardial infarction (MI), and diabetes, for adults aged ≥ 65 years using shared risk factors.
METHODS
METHODS
Data were obtained from 10 population-based cohorts (N = 41,755) with median follow-up time (years) for dementia, stroke, MI, and diabetes of 6.2, 7.0, 6.8, and 7.4, respectively. Disease-free participants at baseline were included, and 22 risk factors (sociodemographic, medical, lifestyle, laboratory biomarkers) were evaluated. Two risk tools (DemNCD and DemNCD-LR based on Fine and Gray sub-distribution and logistic regression [LR], respectively) were developed and validated. Predictive accuracies of these risk tools were assessed using Harrel's C-statistics and area under the curve (AUC) and 95% confidence interval (CI). Model calibration was conducted using Hosmer-Lemeshow goodness of fit test along calibration plots.
RESULTS
RESULTS
Both the DemNCD and DemNCD-LR resulted in similar predictive accuracy for each outcome. The overall AUC (95% CI) for dementia, stroke, MI, and diabetes risk tool were 0·68 (0·65, 0·70), 0·58 (0·54, 0·61), 0·65 (0·61, 0·68), and 0·68 (0·64, 0·72), respectively, for males. For females, these figures were 0·65 (0·63, 0·67), 0·55 (0·52, 0·57), 0·65 (0·62, 0·68), and 0·61 (0·57, 0·65).
CONCLUSIONS
CONCLUSIONS
The DemNCD is the first tool to predict both dementia and multiple cardio-metabolic diseases using comprehensive risk factors and provided similar predictive accuracy to existing risk tools. It has similar predictive accuracy as tools designed for single outcomes in this age-group. DemNCD has the potential to be used in community and clinical settings as it includes self-reported and routinely available clinical measures.
Identifiants
pubmed: 39482675
doi: 10.1186/s12916-024-03711-6
pii: 10.1186/s12916-024-03711-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
501Informations de copyright
© 2024. The Author(s).
Références
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.
pubmed: 32738937
doi: 10.1016/S0140-6736(20)30367-6
World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. 2019.
Tai XY, Veldsman M, Lyall DM, Littlejohns TJ, Langa KM, Husain M, et al. Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study. Lancet Healthy Longev. 2022;3(6):e428–36.
pubmed: 35711612
doi: 10.1016/S2666-7568(22)00117-9
Livingston G, Huntley J, Liu KY, Costafreda SG, Selbæk G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing Commission. Lancet. 2024;404:572.
pubmed: 39096926
doi: 10.1016/S0140-6736(24)01296-0
Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–81.
pubmed: 15668425
doi: 10.1212/01.WNL.0000149519.47454.F2
Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 2017;74(10):1246–54.
pubmed: 28783817
doi: 10.1001/jamaneurol.2017.1658
Anstey KJ, Ee N, Eramudugolla R, Jagger C, Peters R. A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. J Alzheimer’s Dis. 2019;70(s1):S165–86.
doi: 10.3233/JAD-190181
Anstey KJ, Peters R, Mortby ME, Kiely KM, Eramudugolla R, Cherbuin N, et al. Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20–76 years. Sci Rep. 2021;11(1):7710.
pubmed: 33833259
doi: 10.1038/s41598-021-86397-7
Huque MH, Kootar S, Eramudugolla R, Han SD, Carlson MC, Lopez OL, et al. CogDrisk, ANU-ADRI, CAIDE, and LIBRA risk scores for estimating dementia risk. JAMA Network Open. 2023;6:e2331460.
pubmed: 37647064
doi: 10.1001/jamanetworkopen.2023.31460
Anstey KJ, Zheng L, Peters R, Kootar S, Barbera M, Stephen R, et al. Dementia risk scores and their role in the implementation of risk reduction guidelines. Front Neurol. 2022;12:2436.
doi: 10.3389/fneur.2021.765454
Anstey KJ, Kootar S, Huque MH, Eramudugolla R, Peters R. Development of the CogDrisk tool to assess risk factors for dementia. Alzheimer’s Dementia: Diagn Assess Dis Monit. 2022;14(1): e12336.
D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. Framingham Study Stroke. 1994;25(1):40–3.
pubmed: 8266381
doi: 10.1161/01.STR.25.1.40
Parmar P, Krishnamurthi R, Ikram MA, Hofman A, Mirza SS, Varakin Y, et al. The Stroke Riskometer™ app: validation of a data collection tool and stroke risk predictor. Int J Stroke. 2015;10(2):231–44.
pubmed: 25491651
doi: 10.1111/ijs.12411
Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. bmj. 2017;357:j2099.
pubmed: 28536104
pmcid: 5441081
doi: 10.1136/bmj.j2099
Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non–ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42.
pubmed: 10938172
doi: 10.1001/jama.284.7.835
Boulanger M, Li L, Lyons S, Lovett NG, Kubiak MM, Silver L, et al. Essen risk score in prediction of myocardial infarction after transient ischemic attack or ischemic stroke without prior coronary artery disease. Stroke. 2019;50(12):3393–9.
pubmed: 31637970
pmcid: 7597993
doi: 10.1161/STROKEAHA.119.025831
McGorrian C, Yusuf S, Islam S, Jung H, Rangarajan S, Avezum A, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J. 2011;32(5):581–9.
pubmed: 21177699
doi: 10.1093/eurheartj/ehq448
Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. Bmj. 2011;343.
Farnsworth von Cederwald B, Josefsson M, Wåhlin A, Nyberg L, Karalija N. Association of cardiovascular risk trajectory with cognitive decline and incident dementia. Neurology. 2022;98(20):e2013–22.
pubmed: 35444051
pmcid: 9162045
doi: 10.1212/WNL.0000000000200255
Jia R, Wang Q, Huang H, Yang Y, Chung YF, Liang T. Cardiovascular disease risk models and dementia or cognitive decline: a systematic review. Front Aging Neuroscience. 2023;15:1257367.
doi: 10.3389/fnagi.2023.1257367
Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC. Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7(1): 11934.
pubmed: 27327500
pmcid: 4919512
doi: 10.1038/ncomms11934
Low L, Anstey K. Dementia literacy: recognition and beliefs on dementia of the Australian public. Alzheimer’s Dementia. 2009;5(1):43–9.
pubmed: 19118808
doi: 10.1016/j.jalz.2008.03.011
Heger I, Deckers K, van Boxtel M, de Vugt M, Hajema K, Verhey F, et al. Dementia awareness and risk perception in middle-aged and older individuals: baseline results of the MijnBreincoach survey on the association between lifestyle and brain health. BMC Public Health. 2019;19(1):1–9.
doi: 10.1186/s12889-019-7010-z
World Health Organization. Global action plan on the public health response to dementia 2017–2025. 2017.
Chong TW, Rego T, Lai R, Westphal A, Pond CD, Curran E, et al. Preferences and perspectives of Australian general practitioners towards a new “four-in-one” risk assessment tool for preventative health: the LEAD! GP Project J Alzheimer’s Dis. 2023;94(2):801–14.
Kootar S, Huque MH, Kiely KM, Anderson CS, Jorm L, Kivipelto M, et al. Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk. BMJ Open. 2023;13(9): e076860.
pubmed: 37739460
pmcid: 10533692
doi: 10.1136/bmjopen-2023-076860
Investigators ARIC. The atherosclerosis risk in communit (ARIC) study: design and objectives. Am J Epidemiol. 1989;129(4):687–702.
doi: 10.1093/oxfordjournals.aje.a115184
Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1(3):263–76.
pubmed: 1669507
doi: 10.1016/1047-2797(91)90005-W
Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. American Journal of Public Health and the Nations Health. 1951;41(3):279–86.
pmcid: 1525365
doi: 10.2105/AJPH.41.3.279
Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council cognitive function and ageing study (CFAS). Int J Epidemiol. 2006;35(5):1140–5.
pubmed: 16980700
doi: 10.1093/ije/dyl199
Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. The Lancet. 2013;382(9902):1405–12.
doi: 10.1016/S0140-6736(13)61570-6
Sachdev PS, Brodaty H, Reppermund S, Kochan NA, Trollor JN, Draper B, et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70–90 years. Int Psychogeriatr. 2010;22(8):1248–64.
pubmed: 20637138
doi: 10.1017/S1041610210001067
Schievink SH, van Boxtel MP, Deckers K, van Oostenbrugge RJ, Verhey FR, Köhler S. Cognitive changes in prevalent and incident cardiovascular disease: a 12-year follow-up in the Maastricht Aging Study (MAAS). Eur Heart J. 2022;43(7):e2–9.
pubmed: 29020327
doi: 10.1093/eurheartj/ehx365
Langa KM, Plassman BL, Wallace RB, Herzog AR, Heeringa SG, Ofstedal MB, et al. The aging, demographics, and memory study: study design and methods. Neuroepidemiology. 2005;25(4):181–91.
pubmed: 16103729
doi: 10.1159/000087448
Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS. The rush memory and aging project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005;25(4):163–75.
pubmed: 16103727
doi: 10.1159/000087446
Ng TP, Jin A, Feng L, Nyunt MSZ, Chow KY, Feng L, et al. Mortality of older persons living alone: Singapore longitudinal ageing studies. BMC Geriatr. 2015;15:1–9.
doi: 10.1186/s12877-015-0128-7
Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13(3): e0194127.
pubmed: 29558518
doi: 10.1371/journal.pone.0194127
Peters R, Booth A, Rockwood K, Peters J, D’Este C, Anstey KJ. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e022846.
pubmed: 30782689
doi: 10.1136/bmjopen-2018-022846
Yu J-T, Xu W, Tan C-C, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91(11):1201–9.
pubmed: 32690803
doi: 10.1136/jnnp-2019-321913
Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74(4):580–91.
pubmed: 23720230
doi: 10.1002/ana.23944
Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(9): e002495.
pubmed: 27628572
pmcid: 5079002
doi: 10.1161/JAHA.115.002495
Huang Y, Cai X, Li Y, Su L, Mai W, Wang S, et al. Prehypertension and the risk of stroke: a meta-analysis. Neurology. 2014;82(13):1153–61.
pubmed: 24623843
doi: 10.1212/WNL.0000000000000268
Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1· 8 million participants. Lancet (London, England). 2013;383(9921):970–83.
pubmed: 24269108
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. The lancet. 2017;390(10113):2673–734.
doi: 10.1016/S0140-6736(17)31363-6
Anstey KJ, Cherbuin N, Herath PM. Development of a new method for assessing global risk of Alzheimer’s disease for use in population health approaches to prevention. Prev Sci. 2013;14(4):411–21.
pubmed: 23319292
doi: 10.1007/s11121-012-0313-2
Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Muñoz Sánchez JL, Anstey KJ, et al. Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry. 2015;30(3):234–46.
pubmed: 25504093
doi: 10.1002/gps.4245
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. The Lancet Neurology. 2006;5(9):735–41.
pubmed: 16914401
doi: 10.1016/S1474-4422(06)70537-3
Pencina MJ, D’Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation. 2009;119(24):3078–84.
pubmed: 19506114
doi: 10.1161/CIRCULATIONAHA.108.816694
D’Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.
pubmed: 18212285
doi: 10.1161/CIRCULATIONAHA.107.699579
Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167(10):1068–74.
pubmed: 17533210
doi: 10.1001/archinte.167.10.1068
Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010;192(4):197–202.
pubmed: 20170456
doi: 10.5694/j.1326-5377.2010.tb03478.x
von Hippel PT. How many imputations do you need? A two-stage calculation using a quadratic rule. Sociological Methods & Research. 2020;49(3):699–718.
doi: 10.1177/0049124117747303
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
doi: 10.1080/01621459.1999.10474144
Huque MH, Carlin JB, Simpson JA, Lee KJ. A comparison of multiple imputation methods for missing data in longitudinal studies. BMC Med Res Methodol. 2018;18(1):1–16.
doi: 10.1186/s12874-018-0615-6
Austin PC, Lee DS, D’Agostino RB, Fine JP. Developing points-based risk-scoring systems in the presence of competing risks. Stat Med. 2016;35(22):4056–72.
pubmed: 27197622
pmcid: 5084773
doi: 10.1002/sim.6994
Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543–6.
pubmed: 7069920
doi: 10.1001/jama.1982.03320430047030
Hosmer DW Jr. Lemeshow S, Sturdivant RX. Applied logistic regression: John Wiley & Sons; 2013.
Livingstone S, Morales DR, Donnan PT, Payne K, Thompson AJ, Youn J-H, et al. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. The lancet Healthy longevity. 2021;2(6):e352–61.
pubmed: 34100008
pmcid: 8175241
doi: 10.1016/S2666-7568(21)00088-X
van Os HJ, Kanning JP, Ferrari MD, Bonten TN, Kist JM, Vos HMM, et al. Added predictive value of female-specific factors and psychosocial factors for the risk of stroke in women under 50. Neurology. 2023;101(8):e805–14.
pubmed: 37479530
pmcid: 10449433
Kaneko H, Yano Y, Okada A, Itoh H, Suzuki Y, Yokota I, et al. Age-dependent association between modifiable risk factors and incident cardiovascular disease. J Am Heart Assoc. 2023;12(2): e027684.
pubmed: 36628975
pmcid: 9939069
doi: 10.1161/JAHA.122.027684
Pylypchuk R, Wells S, Kerr A, Poppe K, Riddell T, Harwood M, et al. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study. The Lancet. 2018;391(10133):1897–907.
doi: 10.1016/S0140-6736(18)30664-0
Verweij L, Peters RJ, op Reimer WJS, Boekholdt SM, Luben RM, Wareham NJ, et al. Validation of the Systematic COronary Risk Evaluation-Older Persons (SCORE-OP) in the EPIC-Norfolk prospective population study. Int J Cardiol. 2019;293:226–30.
pubmed: 31324398
doi: 10.1016/j.ijcard.2019.07.020
Mehta S, Jackson R, Poppe K, Kerr AJ, Pylypchuk R, Wells S. How do cardiovascular risk prediction equations developed among 30–74 year olds perform in older age groups? A validation study in 125 000 people aged 75–89 years. J Epidemiol Community Health. 2020;74(6):527–33.
pubmed: 32144211
doi: 10.1136/jech-2019-213466
Mielke MM, Zandi P, Sjogren M, Gustafson D, Ostling S, Steen B, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64(10):1689–95.
pubmed: 15911792
doi: 10.1212/01.WNL.0000161870.78572.A5
Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. bmj. 2018;362:k2927.
pubmed: 30068508
pmcid: 6066998
doi: 10.1136/bmj.k2927
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth W, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009;66(3):336–42.
pubmed: 19273752
pmcid: 3513375
doi: 10.1001/archneurol.2008.582
Odden MC, Rawlings AM, Arnold AM, Cushman M, Biggs ML, Psaty BM, et al. Patterns of cardiovascular risk factors in old age and survival and health status at 90. The Journals of Gerontology: Series A. 2020;75(11):2207–14.
Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, et al. Cardiovascular risks associated with gender and aging. Journal of cardiovascular development and disease. 2019;6(2): 19.
pubmed: 31035613
pmcid: 6616540
doi: 10.3390/jcdd6020019
Khan SS, Coresh J, Pencina MJ, Ndumele CE, Rangaswami J, Chow SL, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982–2004.
pubmed: 37947094
doi: 10.1161/CIR.0000000000001191
Kivimäki M, Livingston G, Singh-Manoux A, Mars N, Lindbohm JV, Pentti J, et al. Estimating dementia risk using multifactorial prediction models. JAMA Network Open. 2023;6(6):e2318132-e.
doi: 10.1001/jamanetworkopen.2023.18132